Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2013
12/31/2013US8618131 Biphenyl derivatives
12/31/2013US8618128 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
12/31/2013US8618121 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
12/31/2013US8618102 Bridged diazepan orexin receptor antagonists
12/31/2013CA2755268C Erbb inhibitors
12/31/2013CA2742833C Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
12/31/2013CA2707174C Benzomorphan compounds
12/31/2013CA2630562C Tricyclic compounds useful as inhibitors of kinases
12/31/2013CA2608378C New fluorene derivatives, compositions containing the same and use thereof
12/31/2013CA2587489C Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/27/2013WO2013192350A1 Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
12/27/2013WO2013192347A1 Substituted bicyclic cycloalkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
12/27/2013WO2013192346A1 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mglur5 receptors
12/27/2013WO2013192301A1 Imidazo bicyclic imminium compounds as antitumor agents
12/27/2013WO2013192273A1 Heteroaryl compounds and methods of use thereof
12/27/2013WO2013192049A2 1,2,4-triazine-6-carboxamide kinase inhibitors
12/27/2013WO2013192035A1 Solid forms of a pyrido-pyrimidinium inner salt
12/27/2013WO2013192005A2 Differentiation of human embryonic stem cells into pancreatic endocrine cells
12/27/2013WO2013191988A1 Heterocyclic antimicrobial compounds for use in water - containing systems
12/27/2013WO2013191429A1 Nitrogen-containing heterocyclic compound and organic electronic element comprising same
12/27/2013WO2013191428A1 Nitrogen-containing heterocyclic compound and organic electronic element comprising same
12/27/2013WO2013191355A1 Novel compound and organic electroluminescent element comprising same
12/27/2013WO2013191244A1 Pyridopyrimidin-4-one derivative
12/27/2013WO2013191189A1 Fused heterocyclic compound
12/27/2013WO2013191188A1 Fused heterocyclic compound
12/27/2013WO2013191177A1 Cyclic azine compound, method for producing same, and organic electroluminescent element containing same
12/27/2013WO2013191113A1 Fused heterocyclic compound
12/27/2013WO2013191112A1 Fused heterocyclic compound
12/27/2013WO2013190320A1 Imidazopyridines as inhibitors of aurora kinase and/or flt3
12/27/2013WO2013190319A1 Pharmaceutically active compounds
12/27/2013WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment
12/27/2013WO2012164242A8 Process for the preparation of paliperidone
12/27/2013WO2012162635A8 Metabotropic glutamate receptors 5 modulators and methods of use thereof
12/27/2013WO2012078633A3 Methods of inhibiting metastasis from cancer
12/27/2013CA2877473A1 Imidazo bicyclic imminium compounds as antitumor agents
12/27/2013CA2877469A1 Substituted picolinamide kinase inhibitors
12/27/2013CA2876945A1 1,2,4-triazine-6-carboxamide kinase inhibitors
12/27/2013CA2876941A1 Solid forms of a pyrido-pyrimidinium inner salt
12/27/2013CA2876671A1 Treatment of pluripotent cells
12/27/2013CA2876357A1 Pharmaceutically active compounds
12/27/2013CA2876015A1 Heterocyclic antimicrobial compounds for use in water-containing systems
12/26/2013US20130345426 Tetrahydrocarboline derivative
12/26/2013US20130345254 Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists
12/26/2013US20130345245 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
12/26/2013US20130345240 Compounds that modulate intracellular calcium
12/26/2013US20130345239 Novel crystalline form
12/26/2013US20130345227 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
12/26/2013US20130345218 Inhibitors of influenza viruses replication
12/26/2013US20130345215 Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
12/26/2013US20130345209 Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
12/26/2013US20130345200 Indoles
12/26/2013US20130345197 Azaindoles useful as inhibitors of jak and other protein kinases
12/26/2013US20130345195 Benzodioxane inhibitors of leukotriene production
12/26/2013US20130345193 Compounds that modulate intracellular calcium
12/26/2013US20130345192 Heterocyclic tyrosine kinase inhibitors
12/26/2013US20130345191 1,2,4-triazine-6-carboxamide kinase inhibitors
12/26/2013US20130345190 Isoxazole beta-lactamase inhibitors
12/26/2013US20130345181 Pyrrolopyridineamino derivatives as mps1 inhibitors
12/26/2013US20130344061 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
12/26/2013US20130343992 Radiolabeled pde10a ligands
12/26/2013US20130343988 Pyrido [2, 3-D] pyrimidin-7-one compounds as inhibitors of P13K-Alpha for the treament of cancer
12/25/2013EP2677562A2 Arylamines for organic electroluminescent devices
12/25/2013EP2676958A1 N1-Pyrazolospiroketone acetyl-CoA carboxylase inhibitors
12/25/2013EP2676957A1 Tosylate Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor
12/25/2013EP2675804A1 Tetraazapyrene compounds and their use as n-type semiconductors
12/25/2013EP2675803A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
12/25/2013EP2675795A1 Substituted aminobutyric derivatives as neprilysin inhibitors
12/25/2013EP2675792A1 Substituted aminobutyric derivatives as neprilysin inhibitors
12/25/2013EP2675787A1 Aminoindane compounds and use thereof in treating pain
12/25/2013EP2488514B1 Indole and azaindole modulators of the alpha 7 nachr
12/25/2013EP2465858B1 Process for preparing a pyrido[1,2-a]pyrrolo[1',2':3,4]imidazo[1,2-d]pyrazine-8-carboxamide derivative
12/25/2013EP2429295B1 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
12/25/2013EP2305678B1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof
12/25/2013EP2211620B1 3-PYRAZIN SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AS JANUS KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES
12/25/2013EP2194043B1 Processes
12/25/2013EP2097413B1 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
12/25/2013EP2086539B1 Selective glycosidase inhibitors
12/25/2013CN103476774A Materials for electronic devices
12/25/2013CN103476773A New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103476754A Adamantyl compounds
12/25/2013CN103476417A Compounds and methods of treating diabetes
12/25/2013CN103468247A Molecular tweezer type phenanthroline-benzoxazole fluorescent reagent, as well as preparation method and application thereof
12/25/2013CN103467470A Ocycloimino sugar compound and intermediate, medicament, preparation method and application thereof
12/25/2013CN103467467A Method for preparing Kopsia pauciflora Hook.f. alkaloid B
12/25/2013CN103467466A Synthesis method of moxifloxacin hydrochloride impurity
12/25/2013CN103467448A 7-(3-amino-4-alcoxylimido-1-piperidyl)-1-[(1R, 2S)-2-fluoro-cyclopropyl] quinolone carboxylic acid compounds and preparation methods thereof
12/25/2013CN103467447A Novel organic electroluminescent (EL) material and application thereof in devices
12/25/2013CN103463647A Responsive nuclear magnetic resonance contrast agent based on naphthyridine amide as recognition site and preparation method thereof
12/25/2013CN103122000B High-selectivity c-Met kinase inhibitor used as antitumor drug
12/25/2013CN102757429B Process for producing acehytisine hydrochloride by biologically converting aconitum coreanum hair root
12/25/2013CN102015702B Cyclic ethers
12/25/2013CN101941971B Method for synthesizing evodiamine
12/25/2013CN101679430B 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of ORL-i receptor for treatment of anxiety and depression
12/24/2013US8614323 Chemokine receptor antagonists and use thereof
12/24/2013US8614317 Sulfonamide derivatives of polycyclic dyes used for analytical applications
12/24/2013US8614302 Modified carbocyanine dyes and their conjugates
12/24/2013US8614229 Substituted indole derivatives and methods of use thereof
12/24/2013US8614226 Hetaryl-[1,8]naphthyridine derivatives
12/24/2013US8614221 Inhibitors of Akt activity
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 646